JOHNSON & JOHNSON - 30 Sep 2025 SCHEDULE 13G/A Report for Rapport Therapeutics, Inc. Common Stock, $0.001 par value (RAPP)

Filing Manager
JOHNSON & JOHNSON
Reporting Manager
JOHNSON & JOHNSON
Security
Rapport Therapeutics, Inc. Common Stock, $0.001 par value
Symbol
RAPP
Shares outstanding
36,418,714 shares
Disclosed Ownership
1,784,517 shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Filing time
22 Oct 2025, 17:09:06 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JOHNSON & JOHNSON 4.9% 1,784,517 0 1,784,517 /s/ Marc Larkins Mark Larkins/Secretary
Johnson & Johnson Innovation - JJDC, Inc. 4.9% 1,784,517 0 1,784,517 /s/ Jill McManus Jill McManus/Assistant Treasurer